2023-2029 Global Medications for Canine Atopic Dermatitis Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Medications for Canine Atopic Dermatitis Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Medications for Canine Atopic Dermatitis Market Restraints
Table 3. Medications for Canine Atopic Dermatitis Market Trends
Table 4. Medications for Canine Atopic Dermatitis Industry Policy
Table 5. Global Medications for Canine Atopic Dermatitis Revenue by Company, 2018-2023, US$ million
Table 6. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Company, 2018-2023
Table 7. Global Medications for Canine Atopic Dermatitis Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Medications for Canine Atopic Dermatitis Sales Volume Market Share by Company, 2018-2023
Table 9. Global Medications for Canine Atopic Dermatitis Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Medications for Canine Atopic Dermatitis Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Medications for Canine Atopic Dermatitis Mergers & Acquisitions, Expansion Plans
Table 12. Global Medications for Canine Atopic Dermatitis Manufacturers Product Type
Table 13. China Medications for Canine Atopic Dermatitis Revenue by Company, 2018-2023, US$ million
Table 14. China Medications for Canine Atopic Dermatitis Revenue Market Share by Company, 2018-2023
Table 15. China Medications for Canine Atopic Dermatitis Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Medications for Canine Atopic Dermatitis Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Medications for Canine Atopic Dermatitis Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Medications for Canine Atopic Dermatitis Import & Export Trends
Table 19. Main Sources of China Medications for Canine Atopic Dermatitis Import
Table 20. Export Destination of China Medications for Canine Atopic Dermatitis
Table 21. Global Headquarters and Manufacturing Base of Medications for Canine Atopic Dermatitis Manufacturers
Table 22. Global Major Manufacturers, Medications for Canine Atopic Dermatitis Capacity Expansion and Future Plans
Table 23. Global Medications for Canine Atopic Dermatitis Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Medications for Canine Atopic Dermatitis Production by Region, 2018-2023, (K Units)
Table 25. Global Medications for Canine Atopic Dermatitis Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Medications for Canine Atopic Dermatitis Upstream (Raw Materials)
Table 27. Global Medications for Canine Atopic Dermatitis Typical Customers
Table 28. Medications for Canine Atopic Dermatitis Typical Distributors
Table 29. By Type, Global Medications for Canine Atopic Dermatitis Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Medications for Canine Atopic Dermatitis Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Medications for Canine Atopic Dermatitis Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Medications for Canine Atopic Dermatitis Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Medications for Canine Atopic Dermatitis Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Medications for Canine Atopic Dermatitis Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2018-2029
Table 37. By Country, Global Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2018-2029
Table 39. GlenHaven Company Information, Head Office, Market Area and Industry Position
Table 40. GlenHaven Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 41. GlenHaven Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. GlenHaven Company Profile and Main Business
Table 43. GlenHaven Recent Developments
Table 44. DermaPet Company Information, Head Office, Market Area and Industry Position
Table 45. DermaPet Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 46. DermaPet Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. DermaPet Company Profile and Main Business
Table 48. DermaPet Recent Developments
Table 49. DVM Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 50. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 51. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. DVM Pharmaceuticals Company Profile and Main Business
Table 53. DVM Pharmaceuticals Recent Developments
Table 54. Virbac Company Information, Head Office, Market Area and Industry Position
Table 55. Virbac Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 56. Virbac Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Virbac Company Profile and Main Business
Table 58. Virbac Recent Developments
Table 59. Enzo Life Sciences, Inc. Company Information, Head Office, Market Area and Industry Position
Table 60. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 61. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Enzo Life Sciences, Inc. Company Profile and Main Business
Table 63. Enzo Life Sciences, Inc. Recent Developments
Table 64. Pfizer Animal Health Company Information, Head Office, Market Area and Industry Position
Table 65. Pfizer Animal Health Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 66. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Pfizer Animal Health Company Profile and Main Business
Table 68. Pfizer Animal Health Recent Developments
Table 69. Novartis Animal Health, Inc. Company Information, Head Office, Market Area and Industry Position
Table 70. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 71. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Novartis Animal Health, Inc. Company Profile and Main Business
Table 73. Novartis Animal Health, Inc. Recent Developments
Table 74. Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position
Table 75. Eli Lilly and Company Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 76. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Eli Lilly and Company Company Profile and Main Business
Table 78. Eli Lilly and Company Recent Developments
Table 79. Perrigo Company Information, Head Office, Market Area and Industry Position
Table 80. Perrigo Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 81. Perrigo Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Perrigo Company Profile and Main Business
Table 83. Perrigo Recent Developments
Table 84. Merck & Company Company Information, Head Office, Market Area and Industry Position
Table 85. Merck & Company Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 86. Merck & Company Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Merck & Company Company Profile and Main Business
Table 88. Merck & Company Recent Developments
Table 89. Zoetis Inc. Company Information, Head Office, Market Area and Industry Position
Table 90. Zoetis Inc. Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 91. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Zoetis Inc. Company Profile and Main Business
Table 93. Zoetis Inc. Recent Developments
Table 94. Toray Industries, Inc Company Information, Head Office, Market Area and Industry Position
Table 95. Toray Industries, Inc Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 96. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Toray Industries, Inc Company Profile and Main Business
Table 98. Toray Industries, Inc Recent Developments
Table 99. Bayer Animal Health Company Information, Head Office, Market Area and Industry Position
Table 100. Bayer Animal Health Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 101. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bayer Animal Health Company Profile and Main Business
Table 103. Bayer Animal Health Recent Developments
Table 104. Putney, Inc. Company Information, Head Office, Market Area and Industry Position
Table 105. Putney, Inc. Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 106. Putney, Inc. Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Putney, Inc. Company Profile and Main Business
Table 108. Putney, Inc. Recent Developments
Table 109. Dechra Company Information, Head Office, Market Area and Industry Position
Table 110. Dechra Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 111. Dechra Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Dechra Company Profile and Main Business
Table 113. Dechra Recent Developments
Table 114. Elanco Company Information, Head Office, Market Area and Industry Position
Table 115. Elanco Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 116. Elanco Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Elanco Company Profile and Main Business
Table 118. Elanco Recent Developments
Table 119. Kindred Biosciences Company Information, Head Office, Market Area and Industry Position
Table 120. Kindred Biosciences Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 121. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Kindred Biosciences Company Profile and Main Business
Table 123. Kindred Biosciences Recent Developments
Table 124. Nippon Zenyaku Kogyo Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 125. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Models, Specifications and Application
Table 126. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Nippon Zenyaku Kogyo Co., Ltd. Company Profile and Main Business
Table 128. Nippon Zenyaku Kogyo Co., Ltd. Recent Developments
List of Figure
Figure 1. Medications for Canine Atopic Dermatitis Picture
Figure 2. By Revenue, Global Medications for Canine Atopic Dermatitis Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Medications for Canine Atopic Dermatitis Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Medications for Canine Atopic Dermatitis Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Medications for Canine Atopic Dermatitis Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Medications for Canine Atopic Dermatitis Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Medications for Canine Atopic Dermatitis Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Medications for Canine Atopic Dermatitis Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Medications for Canine Atopic Dermatitis Share of Global Market, 2018-2029
Figure 10. Global Medications for Canine Atopic Dermatitis Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Medications for Canine Atopic Dermatitis Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Medications for Canine Atopic Dermatitis Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Medications for Canine Atopic Dermatitis Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Medications for Canine Atopic Dermatitis Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Medications for Canine Atopic Dermatitis Domestic VS Export, 2022
Figure 16. Global Medications for Canine Atopic Dermatitis Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Medications for Canine Atopic Dermatitis Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Medications for Canine Atopic Dermatitis Production Market Share & Forecast by Region, 2018-2029
Figure 19. Medications for Canine Atopic Dermatitis Industry Chain
Figure 20. Medications for Canine Atopic Dermatitis Procurement Model
Figure 21. Medications for Canine Atopic Dermatitis Sales Model
Figure 22. Medications for Canine Atopic Dermatitis Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. External Use
Figure 25. Injection
Figure 26. By Type, Global Medications for Canine Atopic Dermatitis Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2018-2029
Figure 28. By Type, Global Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Medications for Canine Atopic Dermatitis Price, 2018-2029, (US$/Unit)
Figure 31. Veterinary Hospital
Figure 32. Veterinary Clinic
Figure 33. By Application, Global Medications for Canine Atopic Dermatitis Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2018-2029
Figure 35. By Application, Global Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Medications for Canine Atopic Dermatitis Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2018-2029
Figure 39. By Region, Global Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2018-2029
Figure 40. North America Medications for Canine Atopic Dermatitis Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Medications for Canine Atopic Dermatitis Revenue Market Share, 2022
Figure 42. Europe Medications for Canine Atopic Dermatitis Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Medications for Canine Atopic Dermatitis Revenue Market Share, 2022
Figure 44. Asia Pacific Medications for Canine Atopic Dermatitis Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Medications for Canine Atopic Dermatitis Revenue Market Share, 2022
Figure 46. South America Medications for Canine Atopic Dermatitis Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Medications for Canine Atopic Dermatitis Revenue Market Share, 2022
Figure 48. Middle East & Africa Medications for Canine Atopic Dermatitis Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 51. By Type, U.S. Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 55. By Type, Europe Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 57. China Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 59. By Type, China Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 63. By Type, Japan Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 67. By Type, South Korea Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 71. By Type, Southeast Asia Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 73. India Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 75. By Type, India Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Medications for Canine Atopic Dermatitis Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia Medications for Canine Atopic Dermatitis Market Share, 2022
Figure 79. By Type, Middle East & Asia Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Medications for Canine Atopic Dermatitis Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets